Using microfluidics to improve how cells receive large molecules and particles
Microfluidics to explore ultrafast cell deformations to deliver large cargo via convective transport
This study is exploring a new way to help big molecules and particles get into cells more easily by using a special technology that quickly compresses the cells, making it safer and more effective for treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10910891 on NIH RePORTER |
What this research studies
This research investigates a novel method of delivering large molecules and particles into cells using microfluidic technology. By rapidly compressing cells, the researchers aim to create a pressure-driven flow that allows these substances to enter cells more effectively. This approach addresses current limitations in cell delivery methods, such as the size of molecules that can be delivered and potential damage to the cells. The study focuses on optimizing the conditions under which this rapid compression occurs to enhance the efficiency of the delivery process.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals requiring advanced genetic therapies or those involved in clinical trials for new diagnostic methods.
Not a fit: Patients who are not seeking genetic modifications or do not have conditions that require advanced molecular delivery methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the effectiveness of genetic modifications and diagnostics by enabling the delivery of larger and more complex molecules into cells.
How similar studies have performed: While the approach of using rapid cell compression for molecular delivery is innovative, similar microfluidic techniques have shown promise in other studies, indicating potential for success.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Sulchek, Todd — Georgia Institute of Technology
- Study coordinator: Sulchek, Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.